RECQL4 Affects MHC Class II-mediated Signalling and Favours an Immune-Evasive Signature That Limits Response to Immune Checkpoint Inhibitor Therapy in Patients with Malignant Melanoma
CLINICAL AND TRANSLATIONAL MEDICINE(2025)
Key words
immune evasion,immunotherapy,melanoma,MHC class II,RECQL4
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined